Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism

Kidney International

Volumn 51, Issue 1, 1997, Pages 328-336

  Gogusev, Jean ^b   Duchambon, Patricia ^b   Hory, Bernard ^b   Giovannini, Marc ^b   Goureau, Yann ^b   Sarfati, Emile ^b   Drüeke, Tilman B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PARATHYROID GLAND; PRIORITY JOURNAL;

EID: 0031042732     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.41     Document Type: Article

References (35)

1. SILVER J, MOALLEM E, EPSTEIN E, KILAV R, NAVEH-MANY T: New aspects in the control of parathyroid hormone secretion. Curr Opin Nephrol Hypertens 3:379-385, 1994
2. DRÜEKE T: The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. (Nephrology Forum) Kidney Int 48:259-272, 1995
3. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1442, 1993
4. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 316:1573-1577, 1987
5. 2+-sensing receptor from parathyroid and kidney: New insights into the physiology and pathophysiology of calcium metabolism. (Editorial) Nephrol Dial Transplant 9:1703-1706, 1994
6. LUNDGREN S, HJALM G, HELLMAN P, EK B, JUHLIN C, RASTAD J, KLARESKOG L, ÅKERSTRÖM G, RASK L: A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast cell belongs to the LDL-receptor protein superfamily. Exp Cell Res 212:344-350, 1994
7. JUHLIN C, KLARESKOG L, NYGREN P, LJUNGHALL S, GYLFE E, RASTAD J, ÅKERSTRÖM G: Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology 122:2999-3005, 1988
8. YOUNG WS: Simultaneous use of digoxigenin and radiolabeled oligodeoxyribonucleotide probes for hybridization histochemistry. Neuropeptides 13:271-275, 1989
9. GARRETT JE, TAMIR H, KIFOR O, SIMIN RT, ROGERS KV, MITHAL A, GAGEL RF, BROWN EM: Calcitonin-secreting cells of the thyroid express extracellular calcium receptor gene. Endocrinology 136:5202-5211, 1995
10. MIZE RR, HOLDEFER RN, NABORS LB: Quantitative immunochemistry using an image analyzer. I. Hardware evaluation, image processing, and data analysis. J Neurosci Meth 26:1-24, 1988
11. 2+ sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303, 1993
12. 2+-sensing receptor gene mutation. Nature Genet 8:303-307, 1994
13. HO C, CONNER DA, POLLAK MR, LADD DJ, KIFOR O, WARREN HB, BROWN EM, SEIDMAN JG, SEIDMAN CE: A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nature Genet 11:389-394, 1995
14. THOMPSON DB, SAMOWITZ WS, ODELBERG S, DAVIS RK, SZABO JHH III: Genetic abnormalities in sporadic parathyroid adenomas: Loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metab 80:3377-3380, 1995
15. HOSOKAWA Y, POLLAK MR, BROWN EM, ARNOLD A: The extracellular calcium sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80:3107-3110, 1995
16. GARRETT JE, CAPUANO IV, HAMMERLAND LG, HUNG BCP, BROWN EM, HEBERT SC, NEMETH EF, FULLER F: Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270:12919-12925, 1995
17. BROWN EM, WILSON RE, EASTMAN RC, PALLOTA J, MARYNICK SP: Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to renal chronic renal failure. J Clin Endocrinol Metab 54:172-179, 1982
18. FELSENFELD AJ, LLACH F: Parathyroid gland function in renal failure. Kidney Int 43:771-789, 1993
19. SCHWARZ P, SØRENSEN HA, TRANSBØL I: Inter-relations between the calcium set points of Parfitt and Brown in primary hyperparathyroidism: A sequential citrate and calcium clamp. Eur J Clin Invest 24:553-558, 1994
20. RAMIREZ JA, GOODMAN WG, GORNBEIN J, MENEZES C, MOULTON L, SEGRE GV, SALUSKY IB: Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyrodism. J Clin Endocrinol Metab 76:1489-1494, 1993
21. FELSENFELD AJ, JARA A, PAUL M, BOVER J, RODRIGUEZ M: Differences in the dynamics of parathyroid hormone secretion in hemodialysis patients with marked secondary hyperparathyroidism. J Am Soc Nephrol 6:1371-1378, 1995
22. INDRIDASON OS, QUARLES LD: Non-suppressible parathyroid hormone (PTH) secretion is related to parathyroid gland size in uremic secondary hyperparathyroidism. (abstract) J Am Soc Nephrol 6:964, 1995
23. ROGERS KV, FOX J: Parathyroid gland calcium receptor mRNA levels are unaffected by chronic renal insufficiency or low dietary calcium in rats. Endocrine 3:769-774, 1995
24. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 136: 1419-1425, 1995
25. 3 receptors and duodenal calbindin-D9k in uraemic rats. Eur J Clin Invest 321:521-526, 1991
26. GOGUSEV J, DUCHAMBON P, GIOVANNINI M, CORRÈZE M-C, ZHANG P, INAGAKI C, SARFATI E, DRÜEKE T: Expression of vitamin D (VDR) and Ca-sensing receptor in normal and pathologic human parathyroid tissue. (abstract) Nephrol Dial Transplant 10:931, 1995
27. ARNOLD A, BROWN MF, UREÑA P, GAZ RD, SARFATI E, DRÜEKE TB: Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047-2054, 1995
28. PARETT AM: Hypercalcemic hyperparathymidism following renal transplantation: Differential diagnosis, management and implications for cell population control in the parathyroid gland. Miner Electrol Metab 8:92-112, 1982
29. NAVEH-MANY T, RAHAMIMOV R, LIVNI N, SILVER J: Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96:1786-1793, 1995
30. GOGUSEV J, DUCHAMBON P, STOERMANN-CHOPARD C, GIOVANNINI M, SARFATI E, DRÜEKE TB: De novo expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant (in press)
31. ARNOLD A, STAUNTON CE, KIM HG, GAZ RD, KRONENBERG HM: Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318:658-662, 1988
32. ARNOLD A, KIM HG, GAZ RD, EDDY RL, FUKUSHIMA Y, BYERS MG, SHOWS TB, KRONENBERG HM: Molecular cloning and chromosome mapping of DNA rearranged with the parathyroid hormone gene in parathyroid adenoma. J Clin Invest 83:2034-2040, 1989
33. EL-DEIRY S, LEVINE MA: Molecular overtones of primary hyperparathyroidism. J Clin Endocrinol Metab 80:3105-3106, 1995
34. CARLING T, KINDMARK A, HELLMAN P, LUNDGREN E, LJUNGHALL S, RASTAD J, ÅKERSTRÖM G, MELHUS H: Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Med 1:1309-1311, 1995
35. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598-1606, 1996